The Cooper Companies, Inc. operates within the healthcare sector, presenting a diversified offering through its CooperVision and CooperSurgical segments. With continuous innovation in contact lens solutions and women's healthcare, COO reflects solid growth potential despite sector volatility. Its diversified global presence strengthens its market resilience.
COO's current fundamentals reveal a robust position in terms of returns on assets and equity. A comprehensive analysis of these elements reflects its promising investment value.
| Category | Score | Visualization |
|---|---|---|
| Discounted Cash Flow | 3 | |
| Return on Equity | 3 | |
| Return on Assets | 4 | |
| Debt to Equity | 1 | |
| Price to Earnings | 2 | |
| Price to Book | 3 |
The historical ratings of COO stock reveal consistent performance with moderate improvements over time.
| Date | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|
| April 24, 2026 | 3 | 3 | 3 | 4 | 1 | 2 | 3 |
| Previously | 0 | 3 | 3 | 4 | 1 | 2 | 3 |
Analysts present a positive outlook for COO with strong support for median targets and robust price growth potential.
| High | Low | Median | Consensus |
|---|---|---|---|
| $100 | $73 | $98 | $93.86 |
The current recommendations from analysts show strong market sentiment with a majority leaning towards buy ratings.
| Recommendation | Count | Visualization |
|---|---|---|
| Strong Buy | 0 | |
| Buy | 15 | |
| Hold | 8 | |
| Sell | 1 | |
| Strong Sell | 0 |
With a robust portfolio and innovative offerings, COO stands as a strong contender in the healthcare sector, overcoming industry challenges. Its analysts' consensus as 'Buy' suggests optimism in its long-term growth potential. However, moderate risks are evident in its debt levels, requiring careful monitoring. Overall, COO reveals promising opportunities buoyed by strategic execution and market demand.
Don't leave your profits to chance. Historically, this stock follows specific seasonal patterns that institutional traders use to maximize returns.